CompletedPhase 4NCT00739440

Randomized Controlled Trial to Compare Two Anti-scorpion Serums

Studying Scorpion envenomation

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
Principal Investigator: Jimenez C Ma. Eugenia, PhD
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
Intervention: serum antiscorpion(biological)
Enrollment: 120 target
Eligibility: 15-60 years · All sexes
Timeline: 2008 – 2008

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00739440 on ClinicalTrials.gov

← Back to all trials